Overcoming Nicotine Dependence to Enable Quitting

Recruiting Phase 1 Phase 2 Interventional Study
Tobacco Use Smoking Cessation Smoking Behaviors Nicotine Dependence Nicotine Withdrawal
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
780 (estimated)
Sponsor
Rush University Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Tobacco use disorder is a chronic, relapsing health condition that necessitates a chronic care approach. However, traditional smoking cessation treatment programs allocate nearly all their resources only to those smokers who are willing to set a quit date. This is problematic because few smokers are ready to set a quit date at any given time, and a smoker's stated intention to quit can change rapi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Eligible participants will be males and females who: 1. are 18 years or older 2. report current daily cigarette smoking (≥ 5 cigarettes per day) 3. are not planning to quit in the next 30 days 4. are not currently engaged in smoking cessation treatment 5. are motivated to quit …
Contacts

Maritza Esqueda-Medina

312-563-3702

on-deq@rush.edu

CONTACT

Amanda Mathew

312-563-1273

on-deq@rush.edu

CONTACT